Form 4 for JANX Janux Therapeutics, Inc.
Accepted 2024-10-24 00:00:00 ET · period of report 2024-09-13 · accession 0001415889-24-025601 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-24 | 2024-09-13 | JANX | Lichter Jay | 10% | M - OptEx | $17.29 | +3,815 | 8,868 | +75% | +$66.0K |
| D | 2024-10-24 | 2024-09-13 | JANX | Lichter Jay | 10% | S - Sale+OE | $46.68 | -3,815 | 7,000 | -35% | -$178.1K |
| DM | 2024-10-24 | 2024-09-13 | JANX | Lichter Jay | 10% | M - OptEx | $0.00 | -3,815 | 7,682 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-13 | M | A | 391 | $39.80 | 10,815 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-13 | M | A | 778 | $13.22 | 10,424 | D | — | — | |
| 3 | Common | Common Stock | 2024-09-13 | M | A | 778 | $10.73 | 9,646 | D | — | — | |
| 4 | Common | Common Stock | 2024-09-13 | M | A | 1,868 | $17.00 | 8,868 | D | — | — | |
| 5 | Common | Common Stock | 2024-09-13 | S | D | 3,815 | $46.68 | 7,000 | D | — | — | |
| 6 | Derivative | Stock Option (right to buy) | 2024-09-13 | M | D | 1,868 | $0.00 | 27,138 | D | $17.00 · — to 2027-07-19 | 1,868 Common Stock | (F4) Immediately exercisable. |
| 7 | Derivative | Stock Option (right to buy) | 2024-09-13 | M | D | 778 | $0.00 | 11,308 | D | $13.22 · — to 2027-07-19 | 778 Common Stock | (F4) Immediately exercisable. |
| 8 | Derivative | Stock Option (right to buy) | 2024-09-13 | M | D | 778 | $0.00 | 11,308 | D | $10.73 · — to 2027-07-19 | 778 Common Stock | (F4) Immediately exercisable. |
| 9 | Derivative | Stock Option (right to buy) | 2024-09-13 | M | D | 391 | $0.00 | 7,682 | D | $39.80 · — to 2027-07-19 | 391 Common Stock | (F4) Immediately exercisable. |